BRPI0601390B8 - uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum - Google Patents

uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum

Info

Publication number
BRPI0601390B8
BRPI0601390B8 BRPI0601390A BRPI0601390A BRPI0601390B8 BR PI0601390 B8 BRPI0601390 B8 BR PI0601390B8 BR PI0601390 A BRPI0601390 A BR PI0601390A BR PI0601390 A BRPI0601390 A BR PI0601390A BR PI0601390 B8 BRPI0601390 B8 BR PI0601390B8
Authority
BR
Brazil
Prior art keywords
bauhinioides
bauhinia
protease inhibitors
contortisiliquum
enterolobium
Prior art date
Application number
BRPI0601390A
Other languages
English (en)
Inventor
Miti Nakahata Adriana
Luiza Vilela Oliva Maria
Galvonas Jasiulionis Miriam
Uemura Sampaio Misako
Original Assignee
Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Univ Federal De Sao Paulo Unifesp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp, Univ Federal De Sao Paulo Unifesp filed Critical Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Priority to BRPI0601390A priority Critical patent/BRPI0601390B8/pt
Priority to PCT/BR2007/000088 priority patent/WO2007112531A1/en
Publication of BRPI0601390A publication Critical patent/BRPI0601390A/pt
Publication of BRPI0601390B1 publication Critical patent/BRPI0601390B1/pt
Publication of BRPI0601390B8 publication Critical patent/BRPI0601390B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55Protease inhibitors
    • A61K38/56Protease inhibitors from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum. a presente invenção se refere ao uso de inibidores de proteases isolados a partir da bauhinia bauhinioides e/ou enterolobium contortisiliquum para o tratamento do câncer, bem como de uma composição farmacêutica compreendendo os mesmos.
BRPI0601390A 2006-04-06 2006-04-06 uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum BRPI0601390B8 (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0601390A BRPI0601390B8 (pt) 2006-04-06 2006-04-06 uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum
PCT/BR2007/000088 WO2007112531A1 (en) 2006-04-06 2007-04-09 Use of protease inhibitors from bauhinia bauhinioides and/or enterolobium contortisiliquum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0601390A BRPI0601390B8 (pt) 2006-04-06 2006-04-06 uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum

Publications (3)

Publication Number Publication Date
BRPI0601390A BRPI0601390A (pt) 2007-12-04
BRPI0601390B1 BRPI0601390B1 (pt) 2018-03-13
BRPI0601390B8 true BRPI0601390B8 (pt) 2021-05-25

Family

ID=38563014

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0601390A BRPI0601390B8 (pt) 2006-04-06 2006-04-06 uso de inibidores de proteases de bauhinia bauhinioides e/ou enterolobium contortisiliquum

Country Status (2)

Country Link
BR (1) BRPI0601390B8 (pt)
WO (1) WO2007112531A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113876657B (zh) * 2021-10-29 2023-05-30 柳州两面针股份有限公司 紫荆花提取物在口腔护理用品中的应用

Also Published As

Publication number Publication date
BRPI0601390A (pt) 2007-12-04
BRPI0601390B1 (pt) 2018-03-13
WO2007112531A1 (en) 2007-10-11

Similar Documents

Publication Publication Date Title
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
BRPI0721905B8 (pt) composto inibidor de proteassoma, sua composição farmacêutica e seu uso
CL2011002787A1 (es) Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica.
CO6280490A2 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
MX384206B (es) Formulaciones de inhibidores de dpp iv
CR9949A (es) Inhibidores de proteina activadora de la 5-lipoxigenasa (flap)
BRPI0915084B8 (pt) composto, e, composição farmacêutica
UY31952A (es) 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
CR10868A (es) Derivados de dihidropiridina utiles como inhibidores de la proteina quinasa
BR112012002134B8 (pt) compostos inibidores de apaf-1
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
BRPI0911273B8 (pt) composição farmacêutica compreendendo um inibidor de dpp-iv, bem como processo para sua preparação
GT200800250A (es) Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina
UY31484A1 (es) Piperidinas heteroaril-sustituidas
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
EA201000329A1 (ru) Циклические депсипептиды
BRPI0715176A8 (pt) compostos de heteroarila utéis como inibidores de enzimas de ativação e1
DOP2010000101A (es) Nuevos inhibidores de epoxido hidrolasas soluble (seh) y procedimientos
CU20100111A7 (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso para el tratamiento y prevención de enfermedades pulmonares y cardiovasculares
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
BRPI0713031B8 (pt) composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos
BRPI0911469A8 (pt) Inibidores de gm-csf e il-17 para terapia

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DA RPI 2218 DE 09/07/2013.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AOS DESPACHOS PUBLICADOS NA RPI 2218 DE 09/07/2013 E RPI 2278 DE 02/09/2014

B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 9A ANUIDADE, DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA 221404840430

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 2282 DE 30/09/2014.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2367 DE 17/05/2016

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/04/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF